303 related articles for article (PubMed ID: 25622852)
1. Comparative effectiveness of intravitreal bevacizumab with or without triamcinolone acetonide for treatment of diabetic macular edema.
Jin E; Luo L; Bai Y; Zhao M
Ann Pharmacother; 2015 Apr; 49(4):387-97. PubMed ID: 25622852
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials.
Liu X; Zhou X; Wang Z; Li T; Jiang B
Chin Med J (Engl); 2014; 127(19):3471-6. PubMed ID: 25269916
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
5. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA
Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
Lim JW; Lee HK; Shin MC
Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial.
Ahmadieh H; Ramezani A; Shoeibi N; Bijanzadeh B; Tabatabaei A; Azarmina M; Soheilian M; Keshavarzi G; Mohebbi MR
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):483-9. PubMed ID: 17917738
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M
Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.
Faghihi H; Roohipoor R; Mohammadi SF; Hojat-Jalali K; Mirshahi A; Lashay A; Piri N; Faghihi Sh
Eur J Ophthalmol; 2008; 18(6):941-8. PubMed ID: 18988166
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema-Systematic review, meta-analysis and meta-regression.
Abdel-Maboud M; Menshawy E; Bahbah EI; Outani O; Menshawy A
PLoS One; 2021; 16(1):e0245010. PubMed ID: 33434220
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R
Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786
[TBL] [Abstract][Full Text] [Related]
13. Initial macular thickness and response to treatment in diabetic macular edema.
Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B
Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442
[TBL] [Abstract][Full Text] [Related]
14. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
Bakri SJ; Larson TA
Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravitreal triamcinolone acetonide with intravitreal bevacizumab for treatment of diabetic macular edema: a meta-analysis.
Zhang Y; Ma J; Meng N; Li H; Qu Y
Curr Eye Res; 2013 May; 38(5):578-87. PubMed ID: 23405978
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
Synek S; Vojniković B
Coll Antropol; 2010 Apr; 34 Suppl 2():99-103. PubMed ID: 21305729
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study.
Soheilian M; Rabbanikhah Z; Ramezani A; Kiavash V; Yaseri M; Peyman GA
J Ocul Pharmacol Ther; 2010 Apr; 26(2):199-206. PubMed ID: 20307215
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis and review on the effect of bevacizumab in diabetic macular edema.
Goyal S; Lavalley M; Subramanian ML
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):15-27. PubMed ID: 20665044
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
Lu Y; Su L; Xu X
J Ocul Pharmacol Ther; 2013 Oct; 29(8):702-8. PubMed ID: 23746130
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial.
Ahmadieh H; Taei R; Riazi-Esfahani M; Piri N; Homayouni M; Daftarian N; Yaseri M
Retina; 2011 Oct; 31(9):1819-26. PubMed ID: 21555967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
